Recent Updates
Recently added Catalysts
XTNT Positive Sentiment

Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023

Thursday, November 2, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Xtant Medical Holdings, Inc. has announced that it will release its financial results for the third quarter of 2023 on November 9, 2023. This release is part of the company's commitment to transparency and communication with its investors. The company specializes in surgical solutions for spinal disorders.
Price reaction · baseline $1.19 (2023-11-02 close) · hit after-hours · clean, no other XTNT news in the window
day 0 close · peak
-1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Xtant Medical is preparing to share its financial results.
  • The company is focused on surgical solutions for spinal disorders.
  • The announcement indicates transparency and engagement with stakeholders.

Full Press Release Details

BELGRADE, Mont. , Nov. 02, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended

Frequently Asked Questions

When will Xtant Medical release its Q3 2023 results?

Xtant Medical will release its Q3 2023 financial results on November 9, 2023.

What is Xtant Medical focused on?

Xtant Medical focuses on surgical solutions for the treatment of spinal disorders.

ShareAdd on Google
Tags: XTNT Viatris Investor Conferences Healthcare Xtant Medical spinal disorders financial results surgical solutions
Last updated: Nov 2, 2023

Biotech snapshot

Cash runway
$10M liquidity · $2M/mo burn
~4 mo
High dilution risk